Close Up Radio Welcomes Back Dr. Patricia A. Broderick of Eazysense

New York, NY – Dr. Patricia Broderick is known worldwide as a unique pioneer in nanobiotechnology, leading the frontier in nanosensing biochemistry in the brain to alleviate the burden of brain disorders. Dr. Broderick has dedicated her career to the study of neurodegenerative diseases like epilepsy, Parkinson's and Alzheimer's, as well as biopsychiatric conditions like anxiety, depression, schizophrenia, schizoaffective disorders.

Dr. Broderick is a Medical Professor in Molecular Cellular and Biomedical Sciences at The City University of New York School of Medicine. As the founder of Eazysense Nanotechnologies Inc., Dr. Broderick has invented a patented and trademarked revolutionary technology that will change the way we understand the brain both biologically and chemically: The BRODERICK PROBE®

The BRODERICK PROBE® is designed to diagnose and treat debilitating neurodegenerative and psychiatric brain disorders by showing what the brain is feeling or doing at any precise second. The cutting-edge discoveries made possible by the BRODERICK PROBE® have changed the way that scientists and medical doctors view the brain, its function, dysfunction and treatments.

With the BRODERICK PROBE®, Dr. Broderick has decoded the algorithm for walking to help quadriplegic patients walk again. Neurologists now have a precise and versatile tool. An initial public offering is in the works for the noninvasive use of the tiny biosensor, smaller than a human hair. Dr. Broderick holds the patent as of December 2021.

Dr. Broderick is also the author of the forthcoming Neuroimaging: Sensing Biochemistry in the Brain.